CollPlant Biotechnologies (CLGN) Net Equity Issued and Repurchased (2018 - 2020)
CollPlant Biotechnologies (CLGN) posted Net Equity Issued and Repurchased of -$50000.0 for Q2 2020, down 101.12% on a QoQ basis from $4.4 million in Q1 2020.
CollPlant Biotechnologies (CLGN) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
CollPlant Biotechnologies' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$50000.0 for Q2 2020.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$50000.0 in Q2 2020, while the trailing twelve-month figure through Sep 2020 was $4.9 million (changed N/A YoY) and the FY2021 annual result came in at $50000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$50000.0 for Q2 2020 at CollPlant Biotechnologies, down from $4.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $4.4 million in Q1 2020 and bottomed at -$50000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -50,000.00 |
| Jun 30, 2020 | -50,000.00 |
| Mar 31, 2020 | 4.45 Mn |
| Mar 31, 2020 | 4.45 Mn |
| Mar 31, 2018 | 532,000.00 |
| Mar 31, 2018 | 532,000.00 |